Clinical trial
A Safety and Performance Assessment of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation
NCT05115214 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Performance Assessment of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 19, 2021
- Completion date
- January 15, 2030
- Enrollment
- 150 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.